Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride and finasteride do not increase mood disorder risk in men with hair loss.

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

5-Alpha-Reductase Inhibitors can cause negative side effects.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Cyproterone and finasteride reduced hypersexuality but caused serious side effects.

Finasteride effectively treats benign prostatic hyperplasia by reducing prostate size and improving urinary symptoms.

Finasteride safely lowers DHT levels without affecting testosterone.

Method can accurately measure five BPH drugs at once.

Finasteride slightly improves prostate symptoms but has minimal difference from placebo.

Finasteride solution helps treat hair loss.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

The combination of finasteride, dutasteride, and minoxidil is generally safe for treating male hair loss with minimal side effects.

Finasteride may help reduce male hair loss and excessive hair growth by lowering DHT levels.

Analyzing hair with this method can help understand and monitor scalp conditions and treatment effects.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Flutamide, dutasteride, and finasteride dissolve differently in supercritical carbon dioxide, with dutasteride dissolving the least.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Nanoporous silica entrapped lipid-drug complexes significantly improve the solubility and absorption of drugs that don't dissolve well in water.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Both drugs lower DHT levels, with GI198745 being more effective.